References
- 1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Micro-biol Rev. 2001; 14: 933–951.
- 2. Dashti AA, Jadaon MM, Habeeb FM. Can we rely on one laboratory test in detection of extended-spectrum β-lactamases among Enterobacteriaceae? An evaluation of the Vitek 2 system and comparison with four other detection methods in Kuwait. J Clin Pathol. 2009; 62: 739–742.
- 3. Lal K, Kapil A, Das BK, Sood S. Occurrence of TEM & SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella sp. Isolated from tertiary care hospital. Indian J Med Res. 2007; 125: 173–178.
- 4. Luzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Ste-fani S, Amicosante G, Rossolini GM, Toniolo A. Trends in production of extended-spectrum βl-lacta-mases among Enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol. 2006; 44: 1659–1664.
- 5. www. lahey clinic.org, last modified, august 2013.
- 6. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G. Occurrence of extended-spectrum β-lac-tamases in members of the family Enterobacteria-ceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother. 2002; 46: 196–202.
- 7. Harada S, Ishii Y, Yamaguchi K. Extended-spectrum β-lactamases: Implications for the clinical laboratory and therapy. Korean J Lab Med. 2008; 28: 401–12.
- 8. Oliveira CF, Salla A, Lara VM, Rieger A, Horta JA, Alves SH. Prevalence of extended-spectrum beta-lac-tamases-producing microorganisms in nosocomial patients and molecular characterization of the SHV type isolates. Brasilian J Microb. 2010; 41: 278–282.
- 9. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. Prevalence and spread of extended-spectrum β–lactamase-producing Enterobacteriace-ae in Europe. Clin Microbiol Infect. 2008; 14: 144–153.
- 10. Kaftandzieva A, Kotevska V, Jankoska G, Kjurcik-Trajkovska B, Cekovska Z, Petrovska M. Extended-spectrum beta-lactamase-producing E. coli and Klebsiella pneumoniae in children at University Pediatric Clinic in Skopje. MJMS 2009; 2: 36–41.
- 11. Kaftandzieva A, Kotevska V, Cekovska Z, Jankoska G, Kjurcik-Trajkovska B, Petrovska M. Prevalence and spread of extended-spectrum beta-lactamase-producing E. coli and Klebsiella pneumoniae at Univer sity Clinics in Skopje. Acta Morphol. 2009; 6: 66–71.
- 12. Kaftandzieva A, Trajkovska-Dokic E, Panovski N. Prevalence and molecular characterization of exten ded spectrum beta-lactamases (ESBL)-producing Escherichia coli and Klebsiella pneumoniae. Contribu tions, Sec Biol Med Sci, MASA, XXXII/2, 2011: 129–141.
- 13. Kim J, Jeon S, Lee B, Park M, Lee H, Lee J, Kim S. Rapid detection of extended spectrum β-lactamase (ESBL) for Enterobacteriaceae by use of a multiplex PCR-based method. Infection and Chemotherapy. 2009; 41: 181–184.
- 14. Colom K, Perez J, Alonso R, Fernandez-Aranguiz A, Larino E, Cisterna RSimple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiology Letters. 2003; 223: 147–151.
- 15. Jemima SA, Vergese S. Multiplex PCR for blaTEM & blaSHV in the extended spectrum beta lactamase (ESBL) producing Gram-negative isolates. Indian J Med Res. 2008; 128: 313–317.
- 16. Shahcheraghi F, Nasiri S, Noveiri H. The survey of genes encoding beta-lactamases in Escherichia coli resistant to beta-lactam and non-beta-lactam antibio tics. Iran J Basic Med Sci. 2010; 13: 230–237.
- 17. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A. Norwegian ESBL Study Group. Effects of phenotype and geno type on methods for detection of extended-spectrum-β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol. 2007; 45: 199–205.
- 18. Sorlozano A, Gutierrez J, Luna JD, Soto MJ, Piedrola G. In vitro activity of β-lactam and non-β-lactam antibiotics in extended-spectrum β-lactamase-producing clinical isolates of Escherichia coli. Diagn Microbiol Infect Dis. 2006; 54: 135–139.
- 19. Navarro F, Miro E, Mirelis B. Interpretive reading of the antibiogram of enterobacteria. Enferm Infect Microbiol Clin. 2002; 20: 225–234.
- 20 Jain A, Mondal R. TEM & SHV genes in extended spectrum β-lactamase producing Klebsiella species & their antimicrobial resistance pattern. Indian J Med Res. 2008; 128: 759–764.
- 21. Perez F, Endimiani A, Hujer K, Bonomo R. The con tinuing challenge of ESBLs. Curr Opin Pharmacol. 2007; 7: 459–469.
- 22. Hadziyannis E, Tuohy M, Thomas L, Procop GW, Washington JA, Hall GS. Screening and confirmatory testing for extended spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates. Diagn Microbiol Infect Dis. 2000; 36: 113–117.
- 23. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17: 1791–98.
- 24. Nordmann P, Dortet L, Poirel L. Carbapenem resis tance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012; 18: 263.
- 25. Tzouvelekis LS et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012; 25: 682.